Moderna
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of MRNA would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2018) — listing | $11,477 1.0× | $16,822 1.0× |
| Year 6 (2023) | $4,658 0.9× | $6,791 0.9× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Cambridge, Massachusetts, United States
Popular scenarios with MRNA
For illustration only — not investment advice. Past performance is not indicative of future results.